Sen. Charles Grassley (R-Iowa), who is investigating the safety of health information technology, appears to be interested in exploring whether the Food and Drug Administration should regulate such products.

Grassley has sent letters to Health and Human Services Secretary Kathleen Sebelius, and H. Stephen Lieber, CEO at the Healthcare Information Management and Systems Society, asking for the organizations' views on a 1997 position paper that called for voluntary industry oversight of the integrity of clinical systems rather than regulation. The paper was published in the Journal of the American Medical Informatics Association. The FDA, which started considering regulation in 1996, ultimately declined to do so amid industry opposition.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access